Status:
COMPLETED
Comparison of a Pain Pump Versus Injectable Medication for Analgesia in Knee Arthroscopy
Lead Sponsor:
University of South Alabama
Conditions:
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Hypothesis: Ropivacaine, morphine and ketorolac injected after knee arthroscopy is as effective as this solution plus ropivacaine administered intra-articularly for twenty-four hours. Three groups we...
Detailed Description
Arthroscopic knee patients were randomized to 1 of 3 groups. A) 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5...
Eligibility Criteria
Inclusion
- All subjects who underwent:
- knee arthroscopy + synovectomy
- knee arthroscopy + partial or complete meniscectomy
- knee arthroscopy + chondroplasty
- knee arthroscopy + microfracture
- knee arthroscopy + autologous osteoarticular transplantation
Exclusion
- A surgical procedure that required an incision other then an arthroscopic portal
- A surgical procedure within the same joint within ninety days
- A acute or chronic knee infection
- Any diagnosis of complex regional pain syndrome
- A known allergy to one of the study drugs
- A documented history of narcotic use
- A score of less than two standard deviation on the SF-12 mental component
- Any major systemic or cardiac illness (heart failure, uncontrolled angina, bifascicular blocks, renal insufficiency, or liver disease)
- Under the age of eighteen years
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT01242644
Start Date
October 1 2006
End Date
June 1 2010
Last Update
November 27 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.